國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Molecular imaging in multiple myeloma

Fanti, Stefano.

Molecular imaging in multiple myeloma

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Molecular imaging in multiple myelomaedited by Cristina Nanni, Stefano Fanti, Lucia Zanoni.
其他作者:	Nanni, Cristina.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	v, 136 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Multiple myelomaImaging.
電子資源:	https://doi.org/10.1007/978-3-030-19019-4
ISBN:	9783030190194$q(electronic bk.)

Molecular imaging in multiple myeloma
Molecular imaging in multiple myeloma[electronic resource] /edited by Cristina Nanni, Stefano Fanti, Lucia Zanoni. - Cham :Springer International Publishing :2019. - v, 136 p. :ill., digital ;24 cm.

1.Multiple Myeloma: clinical aspects -- 2. What does a clinician need from new imaging procedures? -- 3.FDG PET in Multiple Myeloma -- 4. Role of Standard Magnetic Resonance Imaging -- 5.Whole Body Diffusion-Weighted Magnetic Resonance Imaging: A new era for whole body imaging in myeloma? -- 6.CXCR4 imaging in Multiple Myeloma -- 7.PET/CT with Standard NON-FDG Tracers -- 8. The issue of interpretation -- 9. Clinical Teachning Cases: FDG PET/CT.

This book provides a comprehensive overview of the importance of molecular imaging in multiple myeloma, with detailed explanation of its clinical impact. Other important features are the definition of criteria that will aid PET/CT interpretation; identification and explanation of the most frequent pitfalls; a brief overview of the advantages and limitations of DWI MR imaging, still an experimental technique in multiple myeloma; and examination of the possible role of emerging PET tracers. When appropriate, clinical cases are used to illustrate key teaching points. All physicians involved in oncological imaging should regularly reassess and update their routine practice in the evaluation of multiple myeloma patients. This is especially true now, given the recent clarification by the International Myeloma Working Group (IMWG) of the criteria for bone damage requiring therapy and the emerging data supporting the role of the newer functional imaging techniques in predicting outcome and/or evaluating response to therapy. In this challenging context, Molecular Imaging in Multiple Myeloma will be of high value for nuclear medicine physicians, radiologists, and hematologists.

ISBN: 9783030190194$q(electronic bk.)

Standard No.: 10.1007/978-3-030-19019-4doiSubjects--Topical Terms:

850809
Multiple myeloma
--Imaging.

LC Class. No.: RC280.B6 / M65 2019

Dewey Class. No.: 616.99418

Molecular imaging in multiple myeloma
LDR:02643nmm a2200337 a 4500 001 565055
003 DE-He213
005 20190702211408.0
006 m d
007 cr nn 008maaau
008 200327s2019 gw s 0 eng d
020 $a 9783030190194$q(electronic bk.)
020 $a 9783030190187$q(paper)
024 7 $a 10.1007/978-3-030-19019-4 $2 doi
026 0 7 $a nam a2200325 a 4500
035 $a 978-3-030-19019-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B6 $b M65 2019
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.99418 $2 23
090 $a RC280.B6 $b M718 2019
245 0 0 $a Molecular imaging in multiple myeloma $h [electronic resource] / $c edited by Cristina Nanni, Stefano Fanti, Lucia Zanoni.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a v, 136 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1.Multiple Myeloma: clinical aspects -- 2. What does a clinician need from new imaging procedures? -- 3.FDG PET in Multiple Myeloma -- 4. Role of Standard Magnetic Resonance Imaging -- 5.Whole Body Diffusion-Weighted Magnetic Resonance Imaging: A new era for whole body imaging in myeloma? -- 6.CXCR4 imaging in Multiple Myeloma -- 7.PET/CT with Standard NON-FDG Tracers -- 8. The issue of interpretation -- 9. Clinical Teachning Cases: FDG PET/CT.
520 $a This book provides a comprehensive overview of the importance of molecular imaging in multiple myeloma, with detailed explanation of its clinical impact. Other important features are the definition of criteria that will aid PET/CT interpretation; identification and explanation of the most frequent pitfalls; a brief overview of the advantages and limitations of DWI MR imaging, still an experimental technique in multiple myeloma; and examination of the possible role of emerging PET tracers. When appropriate, clinical cases are used to illustrate key teaching points. All physicians involved in oncological imaging should regularly reassess and update their routine practice in the evaluation of multiple myeloma patients. This is especially true now, given the recent clarification by the International Myeloma Working Group (IMWG) of the criteria for bone damage requiring therapy and the emerging data supporting the role of the newer functional imaging techniques in predicting outcome and/or evaluating response to therapy. In this challenging context, Molecular Imaging in Multiple Myeloma will be of high value for nuclear medicine physicians, radiologists, and hematologists.
650 0 $a Multiple myeloma $x Imaging. $3 850809
650 0 $a Multiple myeloma $x Molecular aspects. $3 850810
650 1 4 $a Nuclear Medicine. $3 275838
650 2 4 $a Hematology. $3 274899
650 2 4 $a Oncology. $3 195181
700 1 $a Nanni, Cristina. $3 560716
700 1 $a Fanti, Stefano. $3 338217
700 1 $a Zanoni, Lucia. $3 677564
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-19019-4
950 $a Medicine (Springer-11650)